Halozyme Therapeutics Quote - 0J2O

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

18.26

Bid

0.00

Offer

0.00

Volume

0.00

0.00 Day's Range 0.00

18.26 52 Week Range 18.26

Market Cap

2.412B

Previous Close

18.26

Open

Last Trade

4602.25

(O)

Last Trade Time

07:32:29

Financial Volume

VWAP

Average Volume (3m)

1,390

Shares Outstanding

132,098,000

Dividend Yield

PE Ratio

27.09

Earnings Per Share (EPS)

2.13

Revenue

829.25M

Net Profit

281.59M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.halozyme.com

Headquarters

Wilmington, Delaware, USA

Founded

Halozyme Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0J2O. The last closing price for Halozyme Therapeutics was US$18.26. Over the last year, Halozyme Therapeutics shares have traded in a share price range of US$ 18.26 to US$ 18.26.

Halozyme Therapeutics currently has 132,098,000 shares in issue. The market capitalisation of Halozyme Therapeutics is US$2.41 billion. Halozyme Therapeutics has a price to earnings ratio (PE ratio) of 27.09.

No news to show yet.

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	18.26	18.26	18.26	744	18.26	DE
4	18.26	18.26	18.26	914	18.26	DE
12	18.26	18.26	18.26	1390	18.26	DE
26	18.26	18.26	18.26	1416	18.26	DE
52	18.26	18.26	18.26	1038	18.26	DE
156	18.26	18.26	18.26	672	18.26	DE
260	18.26	18.26	18.26	437	18.26	DE

0J2O - Frequently Asked Questions (FAQ)

What is the current Halozyme Therapeutics share price?

The current share price of Halozyme Therapeutics is US$ 18.26

How many Halozyme Therapeutics shares are in issue?

Halozyme Therapeutics has 132,098,000 shares in issue

What is the market cap of Halozyme Therapeutics?

The market capitalisation of Halozyme Therapeutics is USD 2.41B

What is the 1 year trading range for Halozyme Therapeutics share price?

Halozyme Therapeutics has traded in the range of US$ 18.26 to US$ 18.26 during the past year

What is the PE ratio of Halozyme Therapeutics?

The price to earnings ratio of Halozyme Therapeutics is 27.09

What is the cash to sales ratio of Halozyme Therapeutics?

The cash to sales ratio of Halozyme Therapeutics is 9.2

What is the reporting currency for Halozyme Therapeutics?

Halozyme Therapeutics reports financial results in USD

What is the latest annual turnover for Halozyme Therapeutics?

The latest annual turnover of Halozyme Therapeutics is USD 829.25M

What is the latest annual profit for Halozyme Therapeutics?

The latest annual profit of Halozyme Therapeutics is USD 281.59M

What is the registered address of Halozyme Therapeutics?

The registered address for Halozyme Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Halozyme Therapeutics website address?

The website address for Halozyme Therapeutics is www.halozyme.com

Which industry sector does Halozyme Therapeutics operate in?

Halozyme Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EPPEnergypathways Plc	8.25p (47.32%)	2.97M
CLACelsius Resources Limited	0.60p (20.00%)	2.63M
CDLCloudbreak Discovery Plc	0.125p (19.05%)	2.71M
UKRUkrproduct Group Limited	4.00p (17.65%)	3
PETPetrel Resources Plc	1.75p (16.67%)	82.07k
SYNSynergia Energy Ltd	0.0315p (-13.70%)	17.52M
ARCArcontech Group Plc	96.50p (-10.65%)	16.42k
PREMPremier African Minerals Limited	0.0185p (-9.31%)	11.15M
CORCorpus Resources Plc	0.0155p (-8.82%)	53.45M
ADMEAdm Energy Plc	0.16p (-8.57%)	325k
TRPTower Resources Plc	0.028p (1.82%)	258.85M
SYMESupply@me Capital Plc	0.0041p (6.49%)	194.19M
UKOGUk Oil & Gas Plc	0.0115p (-4.17%)	62.89M
CORCorpus Resources Plc	0.0155p (-8.82%)	53.45M
TM1Technology Minerals Plc	0.12p (14.29%)	52.88M